Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "The DEEPER Trial - m-FOLFOXIRI + Cetuximab Treatment & Predictive Clinical Factors for RAS/BRAF Wild-Type and Left-Sided mCRC"

66 views
October 31, 2023
Comments 0
Login to view comments. Click here to Login